Ind-Swift Limited (INDSWFTLTD.NS)
INR 13.03
(-0.61%)
INR 13.03
(-0.61%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.17 Billion INR | -40.05% |
| 2022 | 1.92 Billion INR | 19.38% |
| 2021 | 1.61 Billion INR | 10.47% |
| 2020 | 1.46 Billion INR | 24.13% |
| 2019 | 1.17 Billion INR | 12.31% |
| 2018 | 1.04 Billion INR | 15.53% |
| 2017 | 908.26 Million INR | -8.01% |
| 2016 | 987.37 Million INR | 86.23% |
| 2015 | 530.18 Million INR | 122.54% |
| 2014 | 238.24 Million INR | -71.62% |
| 2013 | 839.49 Million INR | -4.47% |
| 2012 | 878.76 Million INR | 0.0% |
| 2010 | 2.03 Billion INR | 33.17% |
| 2009 | 1.52 Billion INR | 8.8% |
| 2008 | 1.4 Billion INR | 6.99% |
| 2007 | 1.31 Billion INR | 36.82% |
| 2006 | 957.85 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 248.45 Million INR | -30.81% |
| 2023 Q4 | 359.12 Million INR | 88.68% |
| 2023 Q1 | 578.6 Million INR | 20.8% |
| 2023 Q2 | 532.58 Million INR | -7.95% |
| 2023 Q3 | 190.33 Million INR | -64.26% |
| 2023 FY | 1.15 Billion INR | -40.05% |
| 2022 Q3 | 559.84 Million INR | 18.57% |
| 2022 FY | 1.92 Billion INR | 19.38% |
| 2022 Q4 | 478.98 Million INR | -14.44% |
| 2022 Q1 | 418.16 Million INR | 62.63% |
| 2022 Q2 | 472.17 Million INR | 12.91% |
| 2021 Q4 | 257.13 Million INR | -47.3% |
| 2021 Q1 | 414.46 Million INR | 97.32% |
| 2021 FY | 1.61 Billion INR | 10.47% |
| 2021 Q2 | 456.51 Million INR | 10.15% |
| 2021 Q3 | 487.93 Million INR | 6.88% |
| 2020 Q4 | 210.04 Million INR | -57.89% |
| 2020 FY | 1.46 Billion INR | 24.13% |
| 2020 Q2 | 440.16 Million INR | 40.23% |
| 2020 Q3 | 498.84 Million INR | 13.33% |
| 2020 Q1 | 313.88 Million INR | 313.78% |
| 2019 Q2 | 339.66 Million INR | 4.97% |
| 2019 Q4 | 75.85 Million INR | -82.74% |
| 2019 Q3 | 439.43 Million INR | 29.37% |
| 2019 FY | 1.17 Billion INR | 12.31% |
| 2019 Q1 | 323.57 Million INR | 239.09% |
| 2018 FY | 1.04 Billion INR | 15.53% |
| 2018 Q4 | 95.42 Million INR | -63.88% |
| 2018 Q2 | 322.69 Million INR | -16.75% |
| 2018 Q1 | 387.64 Million INR | 353.65% |
| 2018 Q3 | 264.17 Million INR | -18.14% |
| 2017 Q3 | 326.21 Million INR | 0.0% |
| 2017 Q1 | 218.57 Million INR | 5.41% |
| 2017 FY | 908.26 Million INR | -8.01% |
| 2017 Q4 | 85.45 Million INR | -73.81% |
| 2016 Q3 | 244.31 Million INR | -15.25% |
| 2016 FY | 987.37 Million INR | 86.23% |
| 2016 Q1 | 238.24 Million INR | 532.82% |
| 2016 Q2 | 288.28 Million INR | 21.01% |
| 2016 Q4 | 207.35 Million INR | -15.13% |
| 2015 Q2 | 239.37 Million INR | 92.78% |
| 2015 Q4 | -55.04 Million INR | -124.83% |
| 2015 FY | 530.18 Million INR | 122.54% |
| 2015 Q3 | 221.68 Million INR | -7.39% |
| 2015 Q1 | 124.17 Million INR | 141.95% |
| 2014 Q3 | 137.14 Million INR | -28.6% |
| 2014 Q2 | 192.08 Million INR | -6.32% |
| 2014 Q1 | 205.04 Million INR | 997.59% |
| 2014 FY | 238.24 Million INR | -71.62% |
| 2014 Q4 | -296.03 Million INR | -315.85% |
| 2013 Q3 | 296.49 Million INR | 29.25% |
| 2013 Q4 | 18.68 Million INR | -93.7% |
| 2013 Q2 | 229.39 Million INR | -22.22% |
| 2013 FY | 839.49 Million INR | -4.47% |
| 2013 Q1 | 294.92 Million INR | 199.79% |
| 2012 Q4 | 98.37 Million INR | -70.23% |
| 2012 Q3 | 330.41 Million INR | -27.07% |
| 2012 FY | 878.76 Million INR | 0.0% |
| 2012 Q1 | - INR | 0.0% |
| 2012 Q2 | 453.09 Million INR | 0.0% |
| 2010 FY | 2.03 Billion INR | 33.17% |
| 2009 FY | 1.52 Billion INR | 8.8% |
| 2008 FY | 1.4 Billion INR | 6.99% |
| 2007 FY | 1.31 Billion INR | 36.82% |
| 2006 FY | 957.85 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 91.888% |
| Hester Biosciences Limited | 1.27 Billion INR | -70.575% |
| Aarti Drugs Limited | 8.31 Billion INR | 73.876% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 62.744% |
| Albert David Limited | 1.4 Billion INR | -54.29% |
| Alembic Limited | 1 Billion INR | -117.23% |
| Alkem Laboratories Limited | 52.29 Billion INR | 95.846% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -380.486% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -47.61% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -17217.904% |
| Brooks Laboratories Limited | 65.62 Million INR | -3210.776% |
| Eris Lifesciences Limited | 10.42 Billion INR | 79.164% |
| FDC Limited | 6.58 Billion INR | 67.014% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 82.526% |
| Gufic Biosciences Limited | 4.07 Billion INR | 46.67% |
| Hikal Limited | 5.95 Billion INR | 63.536% |
| Innova Captab Limited | 3.46 Billion INR | 37.291% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 53.963% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -232.909% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 88.94% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -15.14% |
| Lupin Limited | 125.09 Billion INR | 98.263% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -214.316% |
| Medico Remedies Limited | 262.14 Million INR | -728.755% |
| Morepen Laboratories Limited | 6.16 Billion INR | 64.739% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 54.957% |
| Orchid Pharma Limited | 2.32 Billion INR | 6.369% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 62.422% |
| RPG Life Sciences Limited | 2.48 Billion INR | 12.504% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -250.139% |
| Sigachi Industries Limited | 2 Billion INR | -8.503% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 231.199% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 47.311% |
| Themis Medicare Limited | 2.42 Billion INR | 10.226% |
| Unichem Laboratories Limited | 4.86 Billion INR | 55.343% |
| Vaishali Pharma Limited | 90.32 Million INR | -2305.291% |
| Wanbury Limited | 1.73 Billion INR | -25.533% |
| Windlas Biotech Limited | 1.33 Billion INR | -62.274% |
| ZIM Laboratories Limited | 1.26 Billion INR | -71.361% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 47.437% |
| Ipca Laboratories Limited | 48.58 Billion INR | 95.528% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.16% |
| Venus Remedies Limited | 2.18 Billion INR | 0.461% |
| Sakar Healthcare Limited | 699.58 Million INR | -210.546% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 98.017% |
| Divi's Laboratories Limited | 32.44 Billion INR | 93.303% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 65.087% |
| Mankind Pharma Limited | 42.19 Billion INR | 94.851% |
| Sequent Scientific Limited | 2.97 Billion INR | 27.065% |
| Laurus Labs Limited | 15.44 Billion INR | 85.937% |
| Neuland Laboratories Limited | 8.24 Billion INR | 73.659% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 85.762% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 96.867% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 98.265% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -3.748% |
| Wockhardt Limited | 7.72 Billion INR | 71.858% |
| Bal Pharma Limited | 770.19 Million INR | -182.075% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 98.672% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 41.21% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -310.581% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 76.402% |
| Shilpa Medicare Limited | 3.56 Billion INR | 39.006% |
| Valiant Laboratories Limited | 138.02 Million INR | -1473.967% |
| Ajanta Pharma Limited | 21.06 Billion INR | 89.686% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -1822.101% |
| Granules India Limited | 16.79 Billion INR | 87.068% |
| Medicamen Biotech Limited | 495.49 Million INR | -338.457% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -288.297% |
| Piramal Enterprises Limited | 8.04 Billion INR | 72.99% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 95.354% |
| NATCO Pharma Limited | 25.73 Billion INR | 91.558% |
| Suven Life Sciences Limited | -200.79 Million INR | 1181.954% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 2097.785% |
| Strides Pharma Science Limited | 14.38 Billion INR | 84.901% |
| Indoco Remedies Limited | 8.04 Billion INR | 72.989% |
| Alpa Laboratories Limited | 188.89 Million INR | -1050.126% |
| Lasa Supergenerics Limited | 121.02 Million INR | -1695.035% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -455.541% |